Best Medications for Panic Attacks
Selective Serotonin Reuptake Inhibitors (SSRIs) are the first-line medication treatment for panic attacks due to their established efficacy, favorable safety profile, and long-term benefits for reducing panic symptoms and preventing relapse. 1
First-Line Medications
SSRIs
SSRIs are strongly recommended for treating panic attacks based on high-quality evidence:
Mechanism: SSRIs inhibit the presynaptic reuptake of serotonin, increasing serotonin availability at the synaptic cleft. This helps modulate fear, worry, and stress responses 1
Specific Options:
- Sertraline (50-200 mg/day)
- Paroxetine
- Fluoxetine
- Fluvoxamine
- Escitalopram
- Citalopram
Efficacy: SSRIs demonstrate significant improvement in:
Dosing Considerations:
- Start with lower doses (e.g., sertraline 25-50 mg/day) and titrate slowly
- Therapeutic effect may take 4-6 weeks to fully develop
- Maximum improvement may require 12 weeks of treatment 1
Potential Side Effects:
- Initial anxiety/agitation (may worsen symptoms temporarily)
- Dry mouth, nausea, diarrhea, headache, somnolence, insomnia
- Sexual dysfunction
- Discontinuation syndrome with missed doses (especially with shorter-acting SSRIs) 1
Second-Line Medications
SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
- Options: Venlafaxine is specifically recommended 1
- Efficacy: Similar response rates to SSRIs (NNT = 4.94) 1
- Considerations: May be appropriate when SSRIs are ineffective or not tolerated
Benzodiazepines
- Options: Alprazolam (2-6 mg/day), clonazepam, diazepam 4, 5
- Benefits:
- Limitations:
- Risk of tolerance and dependence
- Not recommended for long-term use
- Best used as short-term adjunct during SSRI initiation 6
Treatment Algorithm
Initial Treatment:
- Start with an SSRI (sertraline recommended due to favorable side effect profile)
- Begin with low dose (25 mg/day for first week)
- Gradually increase to 50-200 mg/day based on response and tolerability 2
- Consider short-term benzodiazepine during first 2-4 weeks if anxiety is severe
Monitoring:
- Assess response after 4-6 weeks at therapeutic dose
- Use standardized rating scales to track improvement
- Monitor for side effects, especially initial anxiety/agitation
Inadequate Response:
- Optimize SSRI dose if tolerated
- Consider switching to another SSRI
- Alternative: Switch to SNRI (venlafaxine)
Maintenance:
Special Considerations
Initial Worsening: SSRIs may temporarily increase anxiety in the first 1-2 weeks of treatment. Consider starting with subtherapeutic "test" doses 1
Combination Therapy: Consider combining medication with cognitive-behavioral therapy (CBT) for enhanced outcomes 1, 8
Discontinuation: Taper slowly when discontinuing, especially with shorter-acting SSRIs, to avoid withdrawal symptoms 1
Medication Selection Factors:
- Prior response to medication
- Side effect profile
- Comorbid conditions
- Drug interactions (citalopram/escitalopram have fewer CYP450 interactions) 1
While benzodiazepines show strong efficacy in recent meta-analyses 5, their potential for dependence makes SSRIs the preferred first-line treatment for long-term management of panic disorder, with the strongest evidence supporting sertraline as an effective, well-tolerated option with demonstrated long-term benefits 7.